Markey Cancer Center researchers identified a protein that plays an important role in prostate cancer progression as well as resistance to enzalutamide, a common prostate cancer treatment.
A recent University of Kentucky Markey Cancer Center study reveals that having depression before or after a breast cancer diagnosis was associated with a lower likelihood of survival.
The University of Kentucky Markey Cancer Center’s Biospecimen and Translational Pathology Shared Resource Facility (BPTP SRF) was awarded accreditation from the College of American Pathologists (CAP) based on results of a recent on-site inspection.
A new University of Kentucky Markey Cancer Center study published in JCO Oncology Practice found that the use of a financial navigator can significantly reduce financial toxicity for patients with hematologic cancer and their caregivers.
Sally Ellingson, Ph.D. is an assistant professor at the Institute for Biomedical Informatics and also works with the Cancer Research Informatics Shared Resource Facility at the Markey Cancer Center.
The College of Pharmacy will host its 11th annual Therapeutics, Outcomes, Discovery & Delivery (TODD) Symposium from 8 a.m.–5 p.m. April 12, at the Lee T. Todd, Jr. Building.
A recent University of Kentucky Markey Cancer Center study suggests a new radiopharmaceutical compound may be a viable treatment option for patients with advanced cervical cancer.
The study, published in Preventive Medicine Reports, is one of the first to examine the retail availability of disposable e-cigarettes and oral nicotine pouches and gives an early indication the products are targeted to different audiences.
A University of Kentucky Markey Cancer Center program is training the next generation of cancer researchers and healthcare providers to take on the region’s cancer burden.
